StockNews.com Initiates Coverage on Retractable Technologies (NYSE:RVP)

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research report sent to investors on Monday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Down 1.0 %

Retractable Technologies stock opened at $0.80 on Monday. Retractable Technologies has a fifty-two week low of $0.56 and a fifty-two week high of $1.29. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The company has a market capitalization of $23.86 million, a P/E ratio of -1.48 and a beta of 2.08. The stock has a 50-day simple moving average of $0.78 and a 200-day simple moving average of $0.76.

Institutional Trading of Retractable Technologies

A hedge fund recently raised its stake in Retractable Technologies stock. Renaissance Technologies LLC increased its position in Retractable Technologies, Inc. (NYSE:RVP) by 9.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 361,253 shares of the company’s stock after purchasing an additional 31,140 shares during the period. Renaissance Technologies LLC owned 1.21% of Retractable Technologies worth $249,000 at the end of the most recent quarter. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.